Skip to main content
Erschienen in: Journal of Clinical Immunology 1/2007

01.01.2007 | OriginalArticle

CTLA-4 Gene Exon-1 +49 A/G Polymorphism: Lack of Association with Autoimmune Disease in Patients with Common Variable Immune Deficiency

verfasst von: Adina Kay Knight, Davide Serrano, Yaron Tomer, Charlotte Cunningham-Rundles

Erschienen in: Journal of Clinical Immunology | Ausgabe 1/2007

Einloggen, um Zugang zu erhalten

Abstract

The presence of the G allele of exon-1 +49 A/G polymorphisms of the cytotoxic T lymphocyte antigen 4 (CTLA-4) gene has been described as a risk factor associated with the development of autoimmune diseases. Since Common Variable Immune Deficiency (CVID) is associated with autoimmune manifestations in approximately 25% of patients, we sought to examine the association of the CTLA-4 single nucleotide polymorphism with autoimmunity and other inflammatory complications. Sixteen of 47 CVID (34%) patients had a history of autoimmunity, and 15 (32%) had known granulomatous disease with or without lymphoid hyperplasia. CTLA-4 genotype frequencies were AA 40% (19), AG 45% (21), and GG 15% (7). Allele frequencies were A 63% and G 37%, similar to control populations. There were no significant associations between CTLA-4 exon-1 +49 A/G polymorphism and autoimmune or lymphoid hyperplasia and granulomatous disease in this mostly Caucasian CVID patient population.
Literatur
1.
Zurück zum Zitat Brunet JF, et al.: A new member of the immunoglobulin superfamily—CTLA-4. Nature 328(6127):267–70, 1987 PubMedCrossRef Brunet JF, et al.: A new member of the immunoglobulin superfamily—CTLA-4. Nature 328(6127):267–70, 1987 PubMedCrossRef
2.
Zurück zum Zitat Manzotti CN, et al.: Inhibition of human T cell proliferation by CTLA-4 utilizes CD80 and requires CD25 +regulatory T cells. Eur J Immunol 32(10):2888–2896, 2002 PubMedCrossRef Manzotti CN, et al.: Inhibition of human T cell proliferation by CTLA-4 utilizes CD80 and requires CD25 +regulatory T cells. Eur J Immunol 32(10):2888–2896, 2002 PubMedCrossRef
3.
Zurück zum Zitat Gregor PD, et al.: CTLA-4 blockade in combination with xenogeneic DNA vaccines enhances T-cell responses, tumor immunity and autoimmunity to self antigens in animal and cellular model systems. Vaccine 22(13-14):1700–1708, 2004 PubMedCrossRef Gregor PD, et al.: CTLA-4 blockade in combination with xenogeneic DNA vaccines enhances T-cell responses, tumor immunity and autoimmunity to self antigens in animal and cellular model systems. Vaccine 22(13-14):1700–1708, 2004 PubMedCrossRef
4.
Zurück zum Zitat Phan GQ, et al.: Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma. PNAS 100(14):8372–8377, 2003 PubMedCrossRef Phan GQ, et al.: Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma. PNAS 100(14):8372–8377, 2003 PubMedCrossRef
5.
Zurück zum Zitat Attia P, et al.: Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic t-lymphocyte antigen-4. J Clin Oncol 23(25):6043–6053, 2005 PubMedCrossRef Attia P, et al.: Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic t-lymphocyte antigen-4. J Clin Oncol 23(25):6043–6053, 2005 PubMedCrossRef
6.
Zurück zum Zitat Larry W, Moreland RA, Van Den Bosch F, Appelboom T, Leon M, Emery P, Stanley C, Luggen M, Shergy W, Nuamah I, Becker J-C: Costimulatory blockade in patients with rheumatoid arthritis: A pilot, dose-finding, double-blind, placebo-controlled clinical trial evaluating CTLA-4Ig and LEA29Y eighty-five days after the first infusion. Arthrit Rheumat 46(6):1470–1479, 2002 CrossRef Larry W, Moreland RA, Van Den Bosch F, Appelboom T, Leon M, Emery P, Stanley C, Luggen M, Shergy W, Nuamah I, Becker J-C: Costimulatory blockade in patients with rheumatoid arthritis: A pilot, dose-finding, double-blind, placebo-controlled clinical trial evaluating CTLA-4Ig and LEA29Y eighty-five days after the first infusion. Arthrit Rheumat 46(6):1470–1479, 2002 CrossRef
7.
Zurück zum Zitat Kremer JM, et al.: Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. N Engl J Med 349(20):1907–1915, 2003 PubMedCrossRef Kremer JM, et al.: Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. N Engl J Med 349(20):1907–1915, 2003 PubMedCrossRef
8.
Zurück zum Zitat Parry RV, et al.: CD28 and inducible costimulatory protein Src homology 2 binding domains show distinct regulation of phosphatidylinositol 3-kinase, Bcl-xL, and IL-2 expression in primary human CD4 T lymphocytes. J Immunol 171(1):166–174, 2003 PubMed Parry RV, et al.: CD28 and inducible costimulatory protein Src homology 2 binding domains show distinct regulation of phosphatidylinositol 3-kinase, Bcl-xL, and IL-2 expression in primary human CD4 T lymphocytes. J Immunol 171(1):166–174, 2003 PubMed
9.
Zurück zum Zitat Riley JL, et al.: ICOS costimulation requires IL-2 and can be prevented by CTLA-4 engagement. J Immunol 166(8):4943–4948, 2001 PubMed Riley JL, et al.: ICOS costimulation requires IL-2 and can be prevented by CTLA-4 engagement. J Immunol 166(8):4943–4948, 2001 PubMed
10.
Zurück zum Zitat Grimbacher B, et al.: Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol 4(3):261–268, 2003 PubMedCrossRef Grimbacher B, et al.: Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol 4(3):261–268, 2003 PubMedCrossRef
11.
Zurück zum Zitat Di Renzo M, et al.: Enhanced apoptosis of T cells in common variable immunodeficiency (CVID): Role of defective CD28 co-stimulation. Clin Exp Immunol 120(3):503–511, 2000 PubMedCrossRef Di Renzo M, et al.: Enhanced apoptosis of T cells in common variable immunodeficiency (CVID): Role of defective CD28 co-stimulation. Clin Exp Immunol 120(3):503–511, 2000 PubMedCrossRef
12.
Zurück zum Zitat Donner H, et al.: Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto's thyroiditis and Addison's disease. J Clin Endocrinol Metab 82(12):4130–4132, 1997 PubMedCrossRef Donner H, et al.: Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto's thyroiditis and Addison's disease. J Clin Endocrinol Metab 82(12):4130–4132, 1997 PubMedCrossRef
13.
Zurück zum Zitat Ueda H, et al.: Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423(6939):506–511, 2003 PubMedCrossRef Ueda H, et al.: Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423(6939):506–511, 2003 PubMedCrossRef
14.
Zurück zum Zitat Kouki T, et al.: CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. J Immunol 165(11):6606–6611, 2003 Kouki T, et al.: CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. J Immunol 165(11):6606–6611, 2003
15.
Zurück zum Zitat Ban Y, et al.: Analysis of the CTLA-4, CD28, and inducible costimulator (ICOS) genes in autoimmune thyroid disease. Genes Immun 4(8):586–593, 2003 PubMedCrossRef Ban Y, et al.: Analysis of the CTLA-4, CD28, and inducible costimulator (ICOS) genes in autoimmune thyroid disease. Genes Immun 4(8):586–593, 2003 PubMedCrossRef
16.
Zurück zum Zitat Vaidya B, et al.: An association between the CTLA4 exon 1 polymorphism and early rheumatoid arthritis with autoimmune endocrinopathies. Rheumatology 41(2):180–183, 2002 PubMedCrossRef Vaidya B, et al.: An association between the CTLA4 exon 1 polymorphism and early rheumatoid arthritis with autoimmune endocrinopathies. Rheumatology 41(2):180–183, 2002 PubMedCrossRef
17.
Zurück zum Zitat Haller K, et al.: Type 1 diabetes is insulin-2221 MspI and CTLA-4 +49 A/G polymorphism dependent. Eur J Clin Invest 34(8):543–548, 2004 PubMedCrossRef Haller K, et al.: Type 1 diabetes is insulin-2221 MspI and CTLA-4 +49 A/G polymorphism dependent. Eur J Clin Invest 34(8):543–548, 2004 PubMedCrossRef
18.
Zurück zum Zitat Blomhoff A, et al.: Polymorphisms in the cytotoxic T lymphocyte antigen-4 gene region confer susceptibility to Addison's disease. J Clin Endocrinol Metab 89(7):3474–3476, 2004 PubMedCrossRef Blomhoff A, et al.: Polymorphisms in the cytotoxic T lymphocyte antigen-4 gene region confer susceptibility to Addison's disease. J Clin Endocrinol Metab 89(7):3474–3476, 2004 PubMedCrossRef
19.
Zurück zum Zitat Chistiakov D, Turakulov R: CTLA-4 and its role in autoimmune thyroid disease. J Mol Endocrinol 31(1):21–36, 2003 PubMedCrossRef Chistiakov D, Turakulov R: CTLA-4 and its role in autoimmune thyroid disease. J Mol Endocrinol 31(1):21–36, 2003 PubMedCrossRef
20.
Zurück zum Zitat Lee YH, Harley JB, Nath SK: CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): A meta-analysis. Human Genet, 2005 Lee YH, Harley JB, Nath SK: CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): A meta-analysis. Human Genet, 2005
21.
Zurück zum Zitat Bonilla FA, et al.: Practice parameter for the diagnosis and management of primary immunodeficiency. Ann Allergy Asthma Immunol 94(5 Suppl 1):S1–63, 2005 PubMedCrossRef Bonilla FA, et al.: Practice parameter for the diagnosis and management of primary immunodeficiency. Ann Allergy Asthma Immunol 94(5 Suppl 1):S1–63, 2005 PubMedCrossRef
22.
Zurück zum Zitat Warnatz K, et al.: Severe deficiency of switched memory B cells (CD27+IgM-IgD-) in subgroups of patients with common variable immunodeficiency: A new approach to classify a heterogeneous disease. Blood 99(5):1544–1551, 2002 PubMedCrossRef Warnatz K, et al.: Severe deficiency of switched memory B cells (CD27+IgM-IgD-) in subgroups of patients with common variable immunodeficiency: A new approach to classify a heterogeneous disease. Blood 99(5):1544–1551, 2002 PubMedCrossRef
23.
Zurück zum Zitat Piqueras B, et al.: Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. J Clin Immunol 23(5):385–400, 2003 PubMedCrossRef Piqueras B, et al.: Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. J Clin Immunol 23(5):385–400, 2003 PubMedCrossRef
24.
Zurück zum Zitat Ko J, Radigan L, Cunningham-Rundles C: Immune competence and switched memory B cells in common variable immunodeficiency. Clinical Immunol 116(1):37–41, 2005 CrossRef Ko J, Radigan L, Cunningham-Rundles C: Immune competence and switched memory B cells in common variable immunodeficiency. Clinical Immunol 116(1):37–41, 2005 CrossRef
25.
Zurück zum Zitat Fasano MB, et al.: Sarcoidosis and common variable immunodeficiency. Report of 8 cases and review of the literature. Medicine 75(5):251–261, 1996 PubMedCrossRef Fasano MB, et al.: Sarcoidosis and common variable immunodeficiency. Report of 8 cases and review of the literature. Medicine 75(5):251–261, 1996 PubMedCrossRef
26.
Zurück zum Zitat Mechanic LJ, Dikman S, Cunningham-Rundles C: Granulomatous disease in common variable immunodeficiency. Ann Intern Med 127(8):613–617, 1997 PubMed Mechanic LJ, Dikman S, Cunningham-Rundles C: Granulomatous disease in common variable immunodeficiency. Ann Intern Med 127(8):613–617, 1997 PubMed
27.
Zurück zum Zitat Torrelo A, Mediero IG, Zambrano A: Caseating cutaneous granulomas in a child with common variable immunodeficiency. Pediatric Dermatol 12(2):170–173, 1995 Torrelo A, Mediero IG, Zambrano A: Caseating cutaneous granulomas in a child with common variable immunodeficiency. Pediatric Dermatol 12(2):170–173, 1995
28.
Zurück zum Zitat Lun KR, et al.: Granulomas in common variable immunodeficiency: A diagnostic dilemma. Aust J Dermatol 45(1):51–54, 2004 CrossRef Lun KR, et al.: Granulomas in common variable immunodeficiency: A diagnostic dilemma. Aust J Dermatol 45(1):51–54, 2004 CrossRef
29.
Zurück zum Zitat Krupnick AI, et al.: Cutaneous granulomas masquerading as tuberculoid leprosy in a patient with congenital combined immunodeficiency. Mount Sinai J Med 68(4–5):326–330 Krupnick AI, et al.: Cutaneous granulomas masquerading as tuberculoid leprosy in a patient with congenital combined immunodeficiency. Mount Sinai J Med 68(4–5):326–330
30.
Zurück zum Zitat Giannouli S, et al.: Autoimmune manifestations in common variable immunodeficiency. Clin Rheumatol 23(5):449–452, 2004 PubMedCrossRef Giannouli S, et al.: Autoimmune manifestations in common variable immunodeficiency. Clin Rheumatol 23(5):449–452, 2004 PubMedCrossRef
31.
Zurück zum Zitat Mullighan CG, Marshall SE, Welsh KI: Mannose binding lectin polymorphisms are associated with early age of disease onset and autoimmunity in common variable immunodeficiency. Scand J Immunol 51(2):111–122, 2000 PubMedCrossRef Mullighan CG, Marshall SE, Welsh KI: Mannose binding lectin polymorphisms are associated with early age of disease onset and autoimmunity in common variable immunodeficiency. Scand J Immunol 51(2):111–122, 2000 PubMedCrossRef
32.
Zurück zum Zitat Castigli E, et al.: TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat Genet 37(8):829–834, 2005 PubMedCrossRef Castigli E, et al.: TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat Genet 37(8):829–834, 2005 PubMedCrossRef
33.
Zurück zum Zitat Salzer U, et al.: Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet 37(8):820–828, 2005 PubMedCrossRef Salzer U, et al.: Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet 37(8):820–828, 2005 PubMedCrossRef
34.
Zurück zum Zitat Jean-Claude Brouet: ACJ-PFBR: Study of the B cell memory compartment in common variable immunodeficiency. Eur J Immunol 30(9):2516–2520, 2000 Jean-Claude Brouet: ACJ-PFBR: Study of the B cell memory compartment in common variable immunodeficiency. Eur J Immunol 30(9):2516–2520, 2000
35.
Zurück zum Zitat Ko J, Radigan L, Cunningham-Rundles C: Immune competence and switched memory B cells in common variable immunodeficiency. Clin Immunol 116(1):37–41, 2005 PubMedCrossRef Ko J, Radigan L, Cunningham-Rundles C: Immune competence and switched memory B cells in common variable immunodeficiency. Clin Immunol 116(1):37–41, 2005 PubMedCrossRef
36.
Zurück zum Zitat Agematsu K, et al.: Absence of memory B cells in patients with common variable immunodeficiency. Clin Immunol 103(1):34–42, 2002 PubMedCrossRef Agematsu K, et al.: Absence of memory B cells in patients with common variable immunodeficiency. Clin Immunol 103(1):34–42, 2002 PubMedCrossRef
37.
Zurück zum Zitat Jacquot S, et al.: B cell co-receptors regulating T cell-dependent antibody production in common variable immunodeficiency: CD27 pathway defects identify subsets of severely immuno-compromised patients. 871–876, 2001 Jacquot S, et al.: B cell co-receptors regulating T cell-dependent antibody production in common variable immunodeficiency: CD27 pathway defects identify subsets of severely immuno-compromised patients. 871–876, 2001
38.
Zurück zum Zitat Piqueras B, et al.: Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. J Clin Immunol 23(5):385–400, 2003 PubMedCrossRef Piqueras B, et al.: Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. J Clin Immunol 23(5):385–400, 2003 PubMedCrossRef
39.
Zurück zum Zitat Villanueva R, et al.: Limited genetic susceptibility to severe Graves' ophthalmopathy: No role for CTLA-4 but evidence for an environmental etiology. Thyroid 10(9):791–798, 2000 PubMedCrossRef Villanueva R, et al.: Limited genetic susceptibility to severe Graves' ophthalmopathy: No role for CTLA-4 but evidence for an environmental etiology. Thyroid 10(9):791–798, 2000 PubMedCrossRef
40.
Zurück zum Zitat Tomer Y, et al.: CTLA-4 and not CD28 is a susceptibility gene for thyroid autoantibody production. J Clin Endocrinol Metab 86(4):1687–1693, 2001 Tomer Y, et al.: CTLA-4 and not CD28 is a susceptibility gene for thyroid autoantibody production. J Clin Endocrinol Metab 86(4):1687–1693, 2001
41.
Zurück zum Zitat Busse PJ, Razvi S, Cunningham-Rundles C: Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency. J Allergy Clin Immunol 109(6):1001–1004, 2002 PubMedCrossRef Busse PJ, Razvi S, Cunningham-Rundles C: Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency. J Allergy Clin Immunol 109(6):1001–1004, 2002 PubMedCrossRef
42.
Zurück zum Zitat Cunningham-Rundles C: Clinical and immunologic analyses of 103 patients with common variable immunodeficiency. J Clin Immunol 9(1):22–33, 1989 PubMedCrossRef Cunningham-Rundles C: Clinical and immunologic analyses of 103 patients with common variable immunodeficiency. J Clin Immunol 9(1):22–33, 1989 PubMedCrossRef
43.
Zurück zum Zitat Cunningham-Rundles C: Clinical and immunologic studies of common variable immunodeficiency. Curr Opin Pediatr 6(6):676–681, 1994 PubMed Cunningham-Rundles C: Clinical and immunologic studies of common variable immunodeficiency. Curr Opin Pediatr 6(6):676–681, 1994 PubMed
44.
Zurück zum Zitat Cunningham-Rundles C, Bodian C: Common variable immunodeficiency: Clinical and immunological features of 248 patients. Clin Immunol 92(1):34–48, 1999 PubMedCrossRef Cunningham-Rundles C, Bodian C: Common variable immunodeficiency: Clinical and immunological features of 248 patients. Clin Immunol 92(1):34–48, 1999 PubMedCrossRef
45.
Zurück zum Zitat Ballow M: Primary immunodeficiency disorders: Antibody deficiency. J Allergy Clin Immunol 109(4):581–591, 2002 PubMedCrossRef Ballow M: Primary immunodeficiency disorders: Antibody deficiency. J Allergy Clin Immunol 109(4):581–591, 2002 PubMedCrossRef
46.
Zurück zum Zitat Buckley RH: Pulmonary complications of primary immunodeficiencies. Paediatr Respir Rev 5(Suppl 1):S225–S233, 2004 Buckley RH: Pulmonary complications of primary immunodeficiencies. Paediatr Respir Rev 5(Suppl 1):S225–S233, 2004
47.
Zurück zum Zitat Busse PJ, Razvi S, Cunningham-Rundles C: Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency. J Allergy Clin Immunol 109(6):1001–1004, 2002 PubMedCrossRef Busse PJ, Razvi S, Cunningham-Rundles C: Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency. J Allergy Clin Immunol 109(6):1001–1004, 2002 PubMedCrossRef
48.
Zurück zum Zitat Wang J, Cunningham-Rundles C: Treatment and outcome of autoimmune hematologic disease in common variable immunodeficiency (CVID). J Autoimmun 25(1):57–62, 2005 PubMedCrossRef Wang J, Cunningham-Rundles C: Treatment and outcome of autoimmune hematologic disease in common variable immunodeficiency (CVID). J Autoimmun 25(1):57–62, 2005 PubMedCrossRef
49.
Zurück zum Zitat Cunningham-Rundles C, Radigan L: Deficient IL-12 and dendritic cell function in common variable immune deficiency. Clin Immunol 115(2):147–153, 2005 PubMedCrossRef Cunningham-Rundles C, Radigan L: Deficient IL-12 and dendritic cell function in common variable immune deficiency. Clin Immunol 115(2):147–153, 2005 PubMedCrossRef
50.
Zurück zum Zitat Cunningham-Rundles C, et al.: TLR9 activation is defective in common variable immune deficiency. J Immunol 176(3):1978–1987, 2006 PubMed Cunningham-Rundles C, et al.: TLR9 activation is defective in common variable immune deficiency. J Immunol 176(3):1978–1987, 2006 PubMed
Metadaten
Titel
CTLA-4 Gene Exon-1 +49 A/G Polymorphism: Lack of Association with Autoimmune Disease in Patients with Common Variable Immune Deficiency
verfasst von
Adina Kay Knight
Davide Serrano
Yaron Tomer
Charlotte Cunningham-Rundles
Publikationsdatum
01.01.2007
Erschienen in
Journal of Clinical Immunology / Ausgabe 1/2007
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-006-9049-8

Weitere Artikel der Ausgabe 1/2007

Journal of Clinical Immunology 1/2007 Zur Ausgabe

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.